A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.
GSK announces partnerships with Second Harvest, FIRST Robotics, and Les Scientifines to expand support for community health, STEM education, and climate health in Canada; new partners were nominated by employees
Published:
April 18, 2024
by Canada Newswire
|
GlaxoSmithkline Biologicals Gets Patent for Process for the Manipulation of Nucleic Acids
Published:
April 18, 2024
by Biotechnology Patent News
|
GSK reports new long-term data show SHINGRIX vaccine continues to provide high protection against shingles in adults aged 50 and over for more than a decade
Published:
April 17, 2024
by GSK Group (GlaxoSmithKline)
|
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for review by the FDA; vaccine aims to provide broad protection against the five most common bacterial groups that cause invasive meningococcal disease
Published:
April 16, 2024
by GSK Group (GlaxoSmithKline)
|
GlaxoSmithkline Biologicals Seeks Patent for Adjuvants
Published:
April 13, 2024
by Pharmaceutical Patent News
|
Ask us about our Beauty & Personal Care market view